Glyconutrients - Ocrevus (Ocrelizumab) Interaction

Interaction Details

Ocrelizumab is classified as belonging to the following category: Immunosuppressants

Evidence from in vitro research suggests that glyconutrients stimulate certain immune responses. Theoretically, glyconutrients might interfere with immunosuppressive therapy. Immunosuppressant drugs include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.

Interaction Rating

Likelihood of Occurrence

Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists

References

• Lefkowitz DL, Stuart R, Gnade BT, Roberts E, Lefkowitz SS. Effects of a glyconutrient on macrophage functions. Int J Immunopharmacol 2000;22(4):299-308.
• See DM, Cimoch P, Chou S, Chang J, Tilles J. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci 1998;33(3):280-287.
• Haji, Faraji M. and Haji, Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J.Ethnopharmacol. 1999;65(3):231-236.

Ocrelizumab Overview

• Ocrelizumab injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including:

  • primary-progressive forms (symptoms gradually become worse over time) of MS,

  • clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours),

  • relapsing-remitting forms (course of disease where symptoms flare up from time to time), or

  • secondary progressive forms (course of disease where relapses occur more often).

• Ocrelizumab in a class of medications called monoclonal antibodies. It works by stopping certain cells of the immune system from causing damage.

Glyconutrients - More Interactions

Glyconutrients interacts with 111 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.